KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other Working Capital Changes (2016 - 2025)

Regeneron Pharmaceuticals has reported Other Working Capital Changes over the past 17 years, most recently at $423.9 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $423.9 million for Q4 2025, up 2099.53% from a year ago — trailing twelve months through Dec 2025 was $375.3 million (up 64.75% YoY), and the annual figure for FY2025 was $375.3 million, up 64.75%.
  • Other Working Capital Changes for Q4 2025 was $423.9 million at Regeneron Pharmaceuticals, up from -$458.8 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for REGN hit a ceiling of $423.9 million in Q4 2025 and a floor of -$458.8 million in Q3 2025.
  • Median Other Working Capital Changes over the past 5 years was $7.5 million (2022), compared with a mean of $27.7 million.
  • Biggest five-year swings in Other Working Capital Changes: soared 8328.0% in 2021 and later tumbled 1166.98% in 2025.
  • Regeneron Pharmaceuticals' Other Working Capital Changes stood at -$49.0 million in 2021, then fell by 21.63% to -$59.6 million in 2022, then tumbled by 313.59% to -$246.5 million in 2023, then soared by 91.4% to -$21.2 million in 2024, then surged by 2099.53% to $423.9 million in 2025.
  • The last three reported values for Other Working Capital Changes were $423.9 million (Q4 2025), -$458.8 million (Q3 2025), and $230.7 million (Q2 2025) per Business Quant data.